Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2010 1
2011 3
2012 2
2013 1
2014 1
2015 2
2018 2
2019 5
2020 6
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Impact of Stent Graft Thrombosis in Femoropopliteal Arterial Lesions.
Ichihashi S, Takahara M, Iida O, Suzuki K, Yamaoka T, Maeda K, Tobita K, Kobayashi T, Nakama T, Shingaki M, Ozaki S, Akagi D, Soga Y, Iwakoshi S, Fujimura N, Kichikawa K. Ichihashi S, et al. Among authors: ozaki s. JACC Cardiovasc Interv. 2021 May 24;14(10):1137-1147. doi: 10.1016/j.jcin.2021.03.030. JACC Cardiovasc Interv. 2021. PMID: 34016412 Free article.
Short term-efficacy and tolerability of Rheocarna, a novel direct hemoperfusion adsorptive column, for chronic limb-threatening ischemia in dialysis patients: A single-center case series.
Imai E, Kaneko S, Hoshimoto A, Hisada R, Harano M, Anno E, Hagiwara S, Ozaki S, Torii H, Tsukamoto Y. Imai E, et al. Among authors: ozaki s. Ther Apher Dial. 2023 Dec;27(6):1010-1016. doi: 10.1111/1744-9987.14049. Epub 2023 Aug 21. Ther Apher Dial. 2023. PMID: 37605563
Impact of hemodialysis on clinical and angiographic outcomes in in-stent restenotic lesions following optical coherence tomography-guided drug-coated balloon treatment.
Aoki J, Nakazawa G, Ando K, Nakamura S, Tobaru T, Sakurada M, Okada H, Hibi K, Zen K, Ikuta A, Fujii K, Habara M, Ako J, Asano T, Ozaki S, Fusazaki T, Kozuma K; ELEGANT investigators. Aoki J, et al. Among authors: ozaki s. Cardiovasc Interv Ther. 2021 Oct;36(4):429-435. doi: 10.1007/s12928-020-00718-7. Epub 2020 Oct 13. Cardiovasc Interv Ther. 2021. PMID: 33048289
Discovery of (1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist.
Yoshida Y, Naoe Y, Terauchi T, Ozaki F, Doko T, Takemura A, Tanaka T, Sorimachi K, Beuckmann CT, Suzuki M, Ueno T, Ozaki S, Yonaga M. Yoshida Y, et al. Among authors: ozaki s. J Med Chem. 2015 Jun 11;58(11):4648-64. doi: 10.1021/acs.jmedchem.5b00217. Epub 2015 May 22. J Med Chem. 2015. PMID: 25953512
24 results